Nitrosamine Impurity Identification
Nitrosamine Impurity Identification is a methodological framework within pharmaceutical impurity profiling that specifically enables the detection, characterization, and quantification of nitrosamine contaminants in drug substances and products through advanced analytical techniques and risk assessment protocols.
196
Publications
7.2K
Citations
780
Authors
245
Institutions
Publications per year
2017–2026
71
196
Estimation of Steam-Volatile N-Nitrosamines in Foods at the 1 µg/kg Level
Neil Crosby, J. K. Foreman, J. F. Palframan et al. · Nature · 1972 · 142 citations
Carles Planas, Òscar Palacios, Francesc Ventura et al. · Talanta · 2008 · 134 citations
1–5 of 196
780
6
h-index
6
h-index
6
h-index
5
h-index
5
h-index
1–5 of 780
245
Health Canada
Ottawa, Canada
8 h-index
21 publications
807 citations
United States Food and Drug Administration
Silver Spring, United States
8 h-index
39 publications
1.6K citations
Eastern Regional Research Center
Wyndmoor, United States
7 h-index
17 publications
281 citations

Agricultural Research Service
Washington, United States
5 h-index
13 publications
171 citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
4 h-index
10 publications
545 citations
Guangzhou Quality Supervision, Inspection and Research Institute
Guangzhou, China
4 h-index
12 publications
411 citations
Novartis (Switzerland)
Basel, Switzerland
3 h-index
3 publications
90 citations
Pfizer (United States)
New York, United States
3 h-index
11 publications
828 citations
1–8 of 245
25 publications · 1.2K citations
17
h-index
13 publications · 719 citations
13
h-index
10 publications · 312 citations
10
h-index
8 publications · 285 citations
8
h-index
7 publications · 299 citations
7
h-index
1–5